Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Identifying overweight patients at risk of osteoarthritis based on their gut microbiota
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Identifying overweight patients at risk of osteoarthritis based on their gut microbiota
Gastroenterology

Identifying overweight patients at risk of osteoarthritis based on their gut microbiota

Obesity
Gastroenterology

The gut microbiota of overweight patients suffering from osteoarthritis is less abundant and less diversified. As a result, as few as 7 microbial genera could be enough to precisely predict the risk of osteoarthritis in overweight patients.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 14 October 2021
Updated 20 January 2022

Because of the overload imposed on their joints, overweight people are more prone to osteoarthritis. But how to identify those most at risk? The answer could lie in the gut microbiota which is involved in many inflammatory diseases, including osteoarthritis.

Lower microbial diversity in the gut of overweight patients with osteoarthritis

A prospective study was conducted in China on overweight people (25< (sidenote: Body Mass Index.  Ratio of weight in kg to square of height in sq.m ) <30): 182 stool samples from 86 overweight patients with osteoarthritis (25 men and 61 women aged 50 to 72) and 96 overweight volunteers without osteoarthritis (40 men and 56 women aged 50 to 76) were sequenced (16S ribosomal RNA) to characterize their microbial composition. The study found a lower diversity and abundance in the gut microbiota of these overweight subjects in case of osteoarthritis, something that could indicate a disease-associated dysbiosis, according to the authors. The presence of 9 phyla was significantly different (higher or lower content, depending on the phylum) in case of osteoarthritis: for instance, the content of Firmicutes and Bacteroidetes, whose ratio is used as an indicator of dysbiosis, was significantly higher in patients with osteoarthritis. Moreover, 87 bacterial genera were different between overweight patients with and without osteoarthritis. All these bacteria allowed researchers to identify relevant osteoarthritis biomarkers.

Predicting the risk of osteoarthritis based on 7 biomarkers

Based on the previous results, the researchers identified 7 biomarkers found in the gut microbiota that could be used to develop a non-invasive tool for early assessment of the risk of osteoarthritis in overweight people: 3 over-represented bacterial genera in patients with osteoarthritis (Gemmiger, Klebsiella and Akkermansia) and 4 that are under-represented in those same patients (Bacteroides, Prevotella, Alistipes and Parabacteroides). Taken together, these biomarkers are able to precisely predict the risk of osteoarthritis (area under the curve of 83.36%). Among them the Bacteroides genus seems to play such a predominant role that the authors are considering it as a possible target for osteoarthritis treatment.

Source

Wang Z, Zhu H, Jiang Q et al. The gut microbiome as non-invasive biomarkers for identifying overweight people at risk for osteoarthritis. Microb Pathog. 2021 Aug;157:104976.

Tags
Osteoarthritis Inflammation Microbiome Flora
    Created 14 October 2021
    Updated 20 January 2022

    About this article

    To know more about this topic.

    Main topic

    Obesity

    Medical practice

    Gastroenterology

    Content type

    News
    Gastroenterology

    Resilience of healthy adult gut microbiota following antibiotic exposure

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more

    Probiotics: what exactly are we talking about?

    From the Latin pro and Greek bios meaning “for life”, the term “probiotic” was suggested over 60 years ago,...

    Find out more

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial porti...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to suggest a...

    Find out more

    The Janus face of Antibiotics: Life Savers and Microbiota Disruptors

    A page turns: with the advent of antibiotics in the 20th century, this type of therapy, despite its undoubt...

    Find out more

    Fecal transplantation - ready for prime time?

    Congress review By Pr. Danny De Looze Department of Gastroenterology University Hospital Gent, Belgium ...

    Find out more

    Focus on antibiotic associated diarrhea (AAD)

    Find out more

    Continue reading

    News
    28.01.2025

    How to rebuild my gut microbiota after taking antibiotics?

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    09.02.2022

    Antimicrobial resistance genes “stowaway” in gut microbiota during international travel

    Read the article
    08.01.2024

    When travel breeds antibiotic resistance

    Read the article
    08.03.2024

    Revolutionizing Infection Control: FMT's Role in Combatting Multidrug-Resistant Organisms in Transplant Patients

    Read the article
    Actu PRO : La transplantation fécale, solution à l’antibiorésistance chez les patients immunodéprimés ?
    14.05.2019

    Is fecal transplant a solution to prevent antibiotic resistance in immunocompromised patients?

    Read the article
    13.02.2024

    Antibiotics disrupt cancer immunotherapy via gut and immune effects

    Read the article
    24.11.2020

    Antibiotics and risk of IBD in adults

    Read the article
    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    15.10.2025

    How a 7-strain consortium rebuilds the gut to defeat antibiotics resistant bacteria

    Read the article
    Photo HCPs: AMR page for the 2025 WAAW campaign
    08.10.2025

    Everything you need to know about antibiotics and antimicrobial resistance

    Read the article
    07.10.2025

    Phage therapy: a new way to restore the effectiveness of chemotherapy

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo